Table: begin end state 1 5 non-cytoplasmic 6 25 transmembrane 26 30 cytoplasmic 31 53 transmembrane 54 54 cytoplasmic 55 104 non-cytoplasmic 105 131 transmembrane 132 142 cytoplasmic 143 161 transmembrane 162 180 non-cytoplasmic 181 204 transmembrane 205 242 cytoplasmic 243 264 transmembrane 265 282 non-cytoplasmic 283 304 transmembrane 305 315 cytoplasmic 316 334 transmembrane 335 345 non-cytoplasmic 346 368 transmembrane 369 374 cytoplasmic 375 395 transmembrane 396 400 non-cytoplasmic 401 424 transmembrane 425 435 cytoplasmic 436 460 transmembrane 461 461 non-cytoplasmic
Input: >H281DRAFT_04276 H281DRAFT_04276 gluconate permease GntT MEAVHGSTLLVFGVIAIALLILLITRYKVYPFLVLIIVSLLLGLASGMPMATIVKSFETG NGNTLGHIAVVVGLGTMLGKMMAESGGAERIATTLINWFGEKNIHWAMMVVAIIVGLPVF FEVGFVLLIPIAFNVAKRTNKSLLLVGLPMVAGLSVVHGLIPPHPAAMLAVQQYHADIGK TIAYGLIIGVPTAIVAGPLFALLISRYVKLPQENALAAQFLGHDDAAKNGATNTAPKREL PSFGITLFTVLLPVILMLVGSWADLVFTPKTLPNDLLHFVGNSDVALLIAVLVSFWTFGA SRGFNRDQIQKFCGECLAPIAGITLIVGAGGGFGRVLMDSGISKEIVAAATAAHLSPLLF GWLVAALIRLATGSATVAMTTACGIVAPIAAASGVQVKPELLVLATGSGSLIFSHVNDGG FWLIKEYFGMTVGQTFKTWSLLETIISLMGLGLTFALAAVL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server